## Abstract We report the cases of two drug‐resistant major depressed psychotic patients, who were treated with 10 sessions of transcranial magnetic stimulations (TMS) and afterwards with 10 sessions of electroconvulsive therapy (ECT) without changing the concomitant neuroleptic and antidepressive
Transcranial magnetic stimulation (TMS) in the treatment of major depression — a pilot study
✍ Scribed by Hans Martin Kolbinger; Gereon Höflich; Andreas Hufnagel; Hans-Jürgen Müller; Siegfried Kasper
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 500 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
✦ Synopsis
Transcranial magnetic stimulation (TMS) is a diagnostic method well established in neurology. As some effects of TMS are similar to those of electroconvulsive therapy (ECT), we looked for an antidepressant efficacy of TMS in a semi-blinded monocentric pilot study. Fifteen patients with Major Depression (DSM-111-R) were included Ten patients were randomized into two groups and treated with 250 transcranial magnetic stimuli/session for five consecutive days. Stimulus intensity in the two groups was motoric threshold 0.3 tesla respectively. Five patients received placebo stimulation in a similar setting. As assessed by the Hamilton Depression Scale (HAMD), the Clinical Global Impression (CGI), and the Adjective Mood Scale of von Zerssen (Bf-S/Bf-S'), there was an improvement of depressive symptoms in both verum groups, more pronounced in the 'stimulation below threshold' group. Patients in the placebo group did not benefit from stimulation. Our data suggest that TMS might indeed have a relevant antidepressive efficacy.
📜 SIMILAR VOLUMES
## Abstract Repetitive transcranial magnetic stimulation (rTMS) is a relatively new treatment modality for psychiatric patients. rTMS was demonstrated to be effective in the treatment of depression. However, longitudinal outcome studies have not yet been published. Relapse rates are higher in depre
Objective: To assess the efficacy of increasing the number of fast left repetitive transcranial magnetic stimulations (rTMS) (10 Hz @ 120% of motor threshold (MT) over the left dorsolateral prefrontal cortex (DLPFC)) needed to achieve remission in treatment-resistant depression (TRD). And, to determ
## Background: The majority of studies investigating the effectiveness of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depression have focused on high-frequency rTMS to the left prefrontal cortex (HFL-rTMS). In addition, low-frequency right prefrontal rTMS (LFR-rTMS